IT1246328B - Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus. - Google Patents

Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.

Info

Publication number
IT1246328B
IT1246328B IT04845690A IT4845690A IT1246328B IT 1246328 B IT1246328 B IT 1246328B IT 04845690 A IT04845690 A IT 04845690A IT 4845690 A IT4845690 A IT 4845690A IT 1246328 B IT1246328 B IT 1246328B
Authority
IT
Italy
Prior art keywords
procedure
production
carboxylic acids
active agents
fight against
Prior art date
Application number
IT04845690A
Other languages
English (en)
Italian (it)
Other versions
IT9048456A1 (it
IT9048456A0 (it
Inventor
Joachim Kalden
Bernhard Fleckenstein
Andreas Baur
Thomas Harrer
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IT9048456A0 publication Critical patent/IT9048456A0/it
Publication of IT9048456A1 publication Critical patent/IT9048456A1/it
Application granted granted Critical
Publication of IT1246328B publication Critical patent/IT1246328B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT04845690A 1989-11-09 1990-11-08 Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus. IT1246328B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3937325 1989-11-09
DE4015728 1990-05-16

Publications (3)

Publication Number Publication Date
IT9048456A0 IT9048456A0 (it) 1990-11-08
IT9048456A1 IT9048456A1 (it) 1992-05-08
IT1246328B true IT1246328B (it) 1994-11-17

Family

ID=25886910

Family Applications (1)

Application Number Title Priority Date Filing Date
IT04845690A IT1246328B (it) 1989-11-09 1990-11-08 Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.

Country Status (19)

Country Link
US (1) US5334612A ( )
EP (1) EP0427246B1 ( )
JP (1) JPH03188021A ( )
AT (2) AT500684B8 ( )
BE (2) BE1003834A5 ( )
CA (1) CA2029599C ( )
CH (1) CH684054A5 ( )
DE (3) DE9017987U1 ( )
DK (3) DK0427246T3 ( )
ES (2) ES2029769A6 ( )
FR (1) FR2653997B1 ( )
GB (1) GB2239797B ( )
GR (3) GR1000918B ( )
IE (1) IE67874B1 ( )
IT (1) IT1246328B ( )
LU (1) LU87834A1 ( )
NL (1) NL9002438A ( )
PT (1) PT95827B ( )
SE (1) SE508601C2 ( )

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209162D1 (de) * 1991-07-05 1998-03-05 Asta Medica Ag Verwendung von Schwefel enthaltenden Carbonsäuren zur Bekämpfung von pathophysiologisch bedingten Erregungsstörungen
DE4201196C2 (de) * 1992-01-18 1997-05-15 Rabien Margarethe Arzneimittel zur Behandlung der Polyneuropathie
DE4320117A1 (de) * 1992-01-18 1994-12-22 Margarethe Rabien Kombinatinspräparate
ATE160696T1 (de) * 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE9213914U1 (de) * 1992-10-15 1992-12-03 Asta Medica AG, 6000 Frankfurt Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure
CA2159116A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
DE4317173C2 (de) * 1993-05-22 1995-06-14 Asta Medica Ag Verwendung von Dihydroliponsäure als Ophthalmologicum
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
WO1998001440A2 (en) * 1996-07-05 1998-01-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
WO1998023606A1 (fr) * 1996-11-27 1998-06-04 Fuji Kagaku Kogyo Kabushiki Kaisha Derives dithio cycliques, remedes contre des maladies renales diabetiques, agents hypoglycemiques, agents hypolipidemiques et agents lenitifs contre les troubles digestifs
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
CA2352144A1 (en) * 1998-11-25 2000-06-02 Yissum Research Development Company Of The Hebrew University In Jerusale M Scavenger compounds
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
ES2193111T3 (es) * 1999-10-01 2003-11-01 Degussa Forma retardada que contiene (derivados de ) acido alfalipoico.
DE10045904B4 (de) * 1999-10-01 2007-07-12 Degussa Gmbh alpha-Liponsäure(-Derivate) enthaltende Retardform
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
AU2001270554A1 (en) * 2000-06-06 2001-12-17 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US6683110B1 (en) 2001-05-23 2004-01-27 University Of Central Florida Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis
US6649610B1 (en) 2001-05-23 2003-11-18 University Of Central Florida 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
US6686496B1 (en) 2001-06-08 2004-02-03 University Of Central Florida Treatment of myeloma
US6852876B1 (en) 2001-06-08 2005-02-08 University Of Central Florida Treatment of colon cancer
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
EP1476440A4 (en) * 2002-02-22 2005-06-01 Albany College Of Pharmacy METHODS AND COMPOUNDS USEFUL IN INHIBITION BY RADICAL AND / OR OXIDIZING AGGRESSION AND IN THE TREATMENT AND PREVENTION OF DISEASE
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
JP4716666B2 (ja) * 2003-05-21 2011-07-06 有限会社オガ リサーチ α−リポ酸含有水性製剤
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
US20090035403A2 (en) * 2005-06-16 2009-02-05 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
BRPI0621285A2 (pt) * 2006-01-31 2011-12-06 Parsroos Co método para a preparação de um extrato vegetal e processo de produção de uma composição farmacêutica para estìmulo imunológico e/ou tratamento de infecções por hiv que compreende o referido extrato vegetal
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EA200901011A1 (ru) * 2009-06-08 2010-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Белагроген" Препарат на основе интерферона
ES2883956T3 (es) * 2015-05-21 2021-12-09 Ophtalmis Composición oftálmica que comprende ácido lipoico y ácido hialurónico

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA901960A (en) * 1972-06-06 Rossler Richard PROCESS FOR STABILIZING .alpha.-LIPOIC ACID IN PHARMACEUTICAL SOLUTIONS
US2840505A (en) * 1954-04-09 1958-06-24 Du Pont Process of treating animals for metal poisoning with thio-compounds
US2875227A (en) * 1955-05-11 1959-02-24 Merck & Co Inc Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
JPS5026516A ( ) * 1973-07-07 1975-03-19
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPS60146829A (ja) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk テストステロン５α−リダクタ−ゼ阻害剤
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
ATE44464T1 (de) * 1985-03-16 1989-07-15 Wellcome Found Antivirale nukleoside.
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
JP2543096B2 (ja) * 1987-09-24 1996-10-16 松下電器産業株式会社 燃焼装置
ATE70974T1 (de) * 1987-12-04 1992-01-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
JPH01203336A (ja) * 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
JPH03169813A (ja) * 1989-11-09 1991-07-23 Asta Pharma Ag 細胞保護作用を有する疼痛及び炎症性疾患及び／又はレトロウイルスに起因する病気の治療用医薬並びにその製法
JPH10203336A (ja) * 1997-01-17 1998-08-04 Aisin Seiki Co Ltd アンチスキッド制御装置

Also Published As

Publication number Publication date
PT95827A (pt) 1991-09-13
DE4035456A1 (de) 1991-05-16
SE508601C2 (sv) 1998-10-19
PT95827B (pt) 1997-11-28
BE1003834A5 (fr) 1992-06-23
GR900100796A (en) 1992-04-17
IE67874B1 (en) 1996-05-01
JPH03188021A (ja) 1991-08-16
IT9048456A1 (it) 1992-05-08
ATE126053T1 (de) 1995-08-15
SE9003564L (sv) 1991-06-07
GB9024252D0 (en) 1990-12-19
DK173752B1 (da) 2001-09-10
DK0427246T3 (da) 1995-11-27
DK173585B1 (da) 2001-04-02
NL9002438A (nl) 1991-06-03
DE9017987U1 (de) 1993-12-09
DK267790D0 (da) 1990-11-08
EP0427246A3 (en) 1992-06-03
LU87834A1 (de) 1991-05-07
AT500684B1 (de) 2006-10-15
ES2076279T3 (es) 1995-11-01
EP0427246B1 (de) 1995-08-09
GR1001503B (el) 1994-02-28
BE1005018A3 (fr) 1993-03-23
ES2029769A6 (es) 1992-09-01
US5334612A (en) 1994-08-02
DE59009497D1 (de) 1995-09-14
GR1000918B (el) 1993-03-16
IE904035A1 (en) 1991-05-22
GB2239797A (en) 1991-07-17
AT500684B8 (de) 2006-11-15
GR3017695T3 (en) 1996-01-31
FR2653997B1 (fr) 1995-01-20
SE9003564D0 (sv) 1990-11-08
CA2029599C (en) 1998-08-11
CH684054A5 (de) 1994-07-15
EP0427246A2 (de) 1991-05-15
AT500684A1 (de) 2006-02-15
DK200001239A (da) 2000-08-22
IT9048456A0 (it) 1990-11-08
CA2029599A1 (en) 1991-05-10
FR2653997A1 (fr) 1991-05-10
GB2239797B (en) 1994-06-15
DK267790A (da) 1991-05-10

Similar Documents

Publication Publication Date Title
IT1246328B (it) Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.
GR3026161T3 (en) Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders
KR890701559A (ko) 3-인돌피루브산 유도체 및 그의 제약 용도
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
KR890016966A (ko) 신규 항바이러스제
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
DK0920865T3 (da) Farmaceutiske sammensætninger indeholdende norastemizol
IE881994L (en) Substituted azepines and pyrrolidines
MC2091A1 (fr) Procedes pour la preparation de composes a action anti-inflammatoire et de formulations pharmaceutiques les contenant
KR950701922A (ko) 치환된 트리아졸의 설페이트 염, 이를 포함하는 약제학적 조성물 및 치료요법에서의 이의 용도(The sulphate salt of a substituted triazole, pharmaceutical compositions thereof and their use in therapy)
WO1999045909A2 (en) Use of nitrone compounds for the inhibition of angiogenesis
US4188393A (en) Treating spastic conditions or relaxing muscles
IE882703L (en) N-£substituted alkylidene|-1,2,3,4-tetrahydro-9-acridinamines, a process for their preparation and their use as medicaments
US4391809A (en) Methods for treating psoriasis
KR910004192A (ko) 프로페니토인의 치료적 유효량을 함유하는 발작증 치료용 제약 조성물
US4145421A (en) Treating spastic conditions
EP0082546B1 (en) Pharmaceutical mixture and method for making the mixture
DE974353T1 (de) Verwendung von Homocysteinderivaten zur Bereitung eines Medikaments zur verhinderung der Bakterienadhesion
KR930004647B1 (ko) 신장 질환 치료제
KR927003573A (ko) 치료학상 활성인 불소 치환된 벤즈이미다졸, 그의 제조 방법 및 그의 용도
CH666183A5 (it) Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
HUT52384A (en) Process for producing pharmaceutical compositions comprising dianhydrohexitol acyl derivatives
TH9330A (th) คลอโรซับสทิทิวเทดเบนซิมิดาโซลที่ออกฤทธิ์ในทางรักษาโรค
JPH0558883A (ja) 医薬組成物

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961025